• 2 years of experience in cell therapy startup

• 4.5 years at McKinsey&Company as Engagement manager with experience in manufacturing, sourcing, strategy

• PhD, Environmental Eng., Cornell University

• Diplôme d’ingénieur, Ecole Centrale Paris

Founder and CEO

DR. ANTOINE ESPINET

• Experience in microfluidic system design, prototyping and testing

• PhD from Pierre et Marie Curie University in Materials Science

• Post-doctoral researcher (for Sanofi) at the Microfluidics, MEMS, and Nanostructures Lab at Ecole Supérieure de Physique et Chimie Industrielle (ESPCI Paris)

Founder, Head of Microfluidics

DR. CESARE CEJAS

• Experience and PhD in human pluripotent stem cell culture and differentiation from Loughborough University.

• Experience in cell therapy process development and manufacturing optimisation.

• Background in Medicinal Chemistry, International Business and Health economics.

Head of Biology

DR. JAMES KUSENA

• 20 years experience of working in the biopharma sectofr with expertise in all areas of bioprocess development; upstream process, downstream process and analytical development.

• Ex-CEO of Cantab, ex-SVP TEchnical Operations at Abzena

Bioprocessing expert

DR. JIM MILLS

• 25+ years of experience in medical device design and development

• 25+ years of project and multi disciplinary team management in small and large companies (Baxter, blood transfusion systems, Cardio Life Research, cardiac surgery acquired by St Jude Medical)

• 8 years of consulting mostly for medtech start-ups (bariatric surgery, assisted reproductive treatment, hematology..)

System architect

MICHEL JOIE

• 25 years of experience in technology development, particularly in small organisations working in highly regulated environments, with several CTO/COO/CEO/Chairman roles

• PhD in Mechanical Engineering applied to medical devices from Cambridge University

Engineer

DR. TOBY KING

• Director of the drug discovery company, e-Therapeutics plc and the life science investment company Arix Bioscience Plc.

• Boards as Director in the UK: NextPharma Ltd, ReNeuron,BAC BV, Sigma-Tau Finanziaria, Tecnogen SpA, SciClone Inc,and President of Sigma-Tau Pharmaceuticals Inc

• Chair of the HEVER group

Advisor

PROF. TREVOR JONES

• Head of Research and Product development at Mesoblast
  30+ years of experience in stem cell research

• Past president of International Society of Stem Cell Research (ISSCR), C. Harold and Lorine G. Wallace Distinguished Univ.

• Chair at the Univ. of Texas Health Institute, Inaugural Professor and Director, Centre for Stem Cell Research, Brown Foundation Institute of Molecular Medicine

Advisor

DR. PAUL SIMMONS

• Non-executive director at Mesoblast since 2004

• 15 years board experience for various Australian and international biotechnologies companies

• Ex-PwC partner and director

Advisor

MICHAEL SPOONER

• Professor at University of Queensland (Australian Institute of Bioengineering and Nanotechnology)

• Specialised in stem cell regulations in microfluidic devices

• UQ-StemCARE Director

• Past President of both the Australasian Society for Biomaterials and Tissue Engineering

• Numerous industry and startups engagements

Advisor

PROF. JUSTIN COOPER-WHITE